Osoyoos Cannabis is a company poised to process raw cannabis and produce cannabis extracts for Canada’s medicinal and adult-use markets. The company will generate revenue through third-party contract and toll processing, wholesaling of oils and distillates, white-label solutions and through selling Osoyoos Cannabis-branded products.
Osoyoos Cannabis has secured a lease with the Osoyoos Indian Band in Oliver, British Columbia (BC) for a cannabis extraction facility, which will be built out in two phases, the first of which is underway. Once the facility is fully operational, it will be able to process up to 100,000 kilograms of dried flower and produce approximately 9,800 kilograms of cannabis oil annually. The company has also re-submitted its processing license application to Health Canada through the Indigenous Navigator program, which the Company believes will help expedite the licensing process.
The company is also in discussions with the Osoyoos Indian Band to lease over 100 acres of land adjacent to the extraction facility for an outdoor cultivation site. The Okanagan has a hot, dry climate, which makes it an ideal location for outdoor cannabis cultivation.
Osoyoos Cannabis’ company highlights include the following:
- CBD extracts market expected to reach $2.1 billion by 2020
- Four-pronged revenue generation model
- Re-submitted processing license to Health Canada through the Indigenous Navigator program, expediting the application process
- In association with the Osoyoos Indian Band, a well-regarded and entrepreneurial band
- Annual production of approximately 9,800 kilograms of cannabis oil once fully operational
- Led by a strong and experienced management team and board of directors
Flower One Holdings Inc. (CSE:FONE; OTC:FLOOF) recently announced a long-term licensing agreement and brand partnership with CannAmerica Brands Corp. (CSE:CANA,OTCQB:CNNXF) for cannabis product fulfillment in Nevada. Under the agreement, CannAmerica Brands, which is known for its line of top-tier cannabis gummies and edibles, will license Flower One to manufacture, distribute and sell their cannabis Fruit Juice Gummies and Super Soft Gummies in multiple flavors to retailers in Nevada.
“Flower One is thrilled to welcome a true leader in edibles, CannAmerica Brands, to our suite of Brand Partners,” said Ken Villazor, President and CEO of Flower One, in the company’s press release. “We are committed to providing Nevada retailers with reliable access to cannabis across the product spectrum and throughout the value chain. This news marks our official launch into the edibles market, showcasing Flower One’s early capabilities to bring a diversity of products to Nevada at a scale that retailers can rely on.”
In an article discussing the partnership, British Columbia’s The Province publication indicated that Flower One owns and operates 25,000 square feet of cultivation and production space in North Las Vegas. The company is also converting its 455,000-square-foot greenhouse and production facility in Nevada, which will be used for cultivating and processing high-quality cannabis at scale. Lastly, Flower One is also the owner of the NLV Organics consumer brand of cannabis products.
Cannex is working towards becoming a leading vertically-integrated, multi-state cannabis company specializing in boutique cultivation, extraction and manufacturing, as well as brand development, distribution and retail.
Cannex has its roots in Washington State where it owns the assets of Northwest Cannabis Solutions, one of the largest and most profitable cultivators and processors in the state. With its intended transaction with 4Front Holdings LLC, leading experts in the retail, licensing and regulatory aspects of the cannabis business, Cannex will also be expanding operations into Illinois, Maryland, Massachusetts and Pennsylvania. In addition to existing retail dispensaries in these important states, 4Front also brings additional cultivation and processing facilities in Illinois and Massachusetts on top of a very experienced team.
Cannex’s company highlights include the following:
- Transformational acquisition of 4Front allows immediate expansion into Illinois, Maryland, Massachusetts and Pennsylvania;
- Near-term M&A expansion opportunities into California, Michigan, Nevada and Arizona.
- Pending license applications in Ohio, Arkansas and Connecticut.
- Industry-leading yields of over 400 grams per square feet at Washington facilities.
- Cannex strategic tenant, NWCS, is largest producer and processor in Washington.
- NWCS grows, produces and sells top-selling Washington flower brands as well as the top edible and derivative products in the state.
- NWCS has developed 16 leading brands and distributes over 300 SKUs to more than 300 Washington retail dispensaries.
- Gotham Green’s $32 million investment gives Cannex exceptional balance sheet strength.
- Management and insiders have significant ownership stake.
While he may not have advocated for the legalization of cannabis during his presidency, former president of Mexico, Vicente Fox, has become a proponent for a regulated market in the Latin American country. Fox, who now sits on the board of medical cannabis company Khiron Life Sciences (TSXV:KHRN), is using his post-presidential platform to educate audiences on how legalization could bolster Mexico’s economy and tackle the cannabis black market.
In a recent interview published by Forbes, Fox spoke about Mexico’s potential, referring to its growing medical industry, where Khiron is preparing to roll out its patient-focused products. He believes that Mexico will be the third country to legalize adult-use cannabis at the federal level, following Uruguay and Canada. He believes that this is a prime time for investors to focus on this emerging market and the companies that are involved in it.
“It’s also important for investors to understand that the cannabis industry has high return rates for the time being, especially in emerging markets. So, cannabis investments in Mexico can be recuperated much faster than usual,” he said in the interview. “We still have 5 to 10 years of high profitability still ahead of us.”
To read the full interview, click here.
Cannara Biotech is building a vertically-integrated cannabis company focused on cultivating and developing cannabis-infused products at their 625,000-square-foot indoor cultivation facility – one of the largest in Canada and largest to date in Quebec. Once operational, the facility will contain 500,000 square feet of production space, 100,000 square feet of processing space and will have an annual production capacity of 100,000 kilograms of cannabis.
Through Cannara’s collaborative corridor initiative, the company intends to lease space to product manufacturers developing cannabis-infused products and expedite them to the market. Cannara is currently in discussions with partners to produce edibles, pet products, cosmetics, beverages and more within the facility, once the appropriate regulations come into effect.
In addition to their facility in Quebec, Cannara has entered the US hemp and cannabidiol (CBD) market through the e-commerce platform, shopCBD.com, which will showcase hemp and CBD manufacturers throughout the US. The site will offer tinctures, oils, capsules, body care, vape cartridges and pet-related products to US consumers.
Cannara’s company highlights include the following:
- Canadian cannabis sales expected to reach $7.17 billion in 2019.
- Quebec’s recreational cannabis market expected to generate between $420 million and $1 billion in sales in 2019.
- Quebec has lowest cost per gram and electricity rates in Canada.
- 625,000-square-foot indoor, multi-purpose cultivation facility under construction in Farnham, Quebec.
- Phase one construction fully-funded. Phases two and three to be funded through tenants.
- IP portfolio with 19 filed patents and 40 granted domain names and trademarks.
- Seven brands across medical, recreational, pet care, cosmeceutical, beverage and edible markets.
- Ongoing R&D to develop new products and formulations to address consumer demand.
- US hemp-derived CBD market is expected to reach $22 billion by 2022.
Following the merger of Potash Corp. and Agrium Inc., which will now exist as Nutrien Ltd., the ticker symbol “POT” became available on all Canadian stock exchanges. Due to high demand from approximately 40 companies in Canada’s cannabis industry to appropriate the stock symbol, the exchanges hosted a lottery for any interested companies listed on the TSX, TSXV, CSE and Aequitas NEO Exchange.
On February 1, Weekend Unlimited (CSE:YOLO, FSE:0OS1) was announced as the winner. Weekend Unlimited is working on the west coast to establish a lifestyle brand featuring premium products and led by business and cannabis industry leaders.
“Weekend Unlimited is thrilled to add the iconic POT trading symbol to its identity,” said Paul Chu, Weekend Unlimited President and CEO in a press release. “As a fast-growing multi-state operator, Weekend Unlimited is developing lifestyle brands around recreational and wellness to help define the future of the cannabis industry. The POT symbol is a tremendous fit with our brand identity.”
According to a Bloomberg article, Weekend Unlimited’s shares surged as much as 65 percent following the announcement, raising a market value listed at C$28.6 million. According to Chu, the lottery benefitted both the company and the Canadian cannabis industry as a whole. ” The POT lottery served to raise the profile of Canada’s leadership in legal recreational cannabis and we believe it will also serve to raise Weekend Unlimited’s leadership profile.”
Click here to read the full article.